Jopaul Mathew

Jopaul Mathew

Auto-generated profile, based on publicly available information

Jopaul Mathew

Oak Ridge National Laboratory

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 October 2023 in Scientific Reports
Verified
Journal Article
Open access
PDF file
CPCorey D. Pilgrim
Corey D. Pilgrim
TGTravis Grimes
Travis Grimes
CSClayn Smith
Clayn Smith
CHColt R. Heathman
Colt R. Heathman
JMJopaul Mathew
Jopaul Mathew
PZPeter R. Zalupski
Peter R. Zalupski
The complexation of trivalent lanthanides and minor actinides (Am3+, Cm3+, and Cf3+) by the acyclic aminopolycarboxylate chelators 6,6′-((ethane-1,2-diylbis–((carboxymethyl)azanediyl))bis–(methylene))dipicolinic acid (H4octapa) and 6,6'-((((4-(1-(2-(2-(2-hydroxyethoxy)ethoxy)ethyl)-1H-1,2,3-triazol-4-yl)pyridine-2,6-diyl)bis–(methylene))bis–((carboxymethyl)azanediyl))bis–(methylene)) dipicolinic acid (H4pypa-peg) were studied using potentiometry, spectroscopy, competitive complexation liquid–liquid extraction, and ab initio molecular dynamics simulations. Two studied reagents are strong multidentate chelators, well-suited for applications seeking radiometal coordination for in-vivo delivery and f-element isolation. The previously reported H4octapa forms a compact coordination packet, while H4pypa-peg is less sterically constrained due to the presence of central pyridine ring. The solubility of H4octapa is limited in a non-complexing high ionic strength perchlorate media. However, the introduction of a polyethylene glycol group in H4pypa-peg increased the solubility without influencing its ability to complex the lanthanides and minor actinides in solution.

28 October 2024 in ACS Infectious Diseases
Verified
Journal Article
Closed access
JMJopaul Mathew
Jopaul Mathew
BZBo Zhou
Bo Zhou
RHReagan S. Haney
Reagan S. Haney
KKKevin A. Kunz
Kevin A. Kunz
LALeticia S. Do Amaral
Leticia S. Do Amaral
PCPaul R. Carlier
Paul R. Carlier

17 October 2025 in ACS Infectious Diseases
Verified
Journal Article
Open access
RHReagan S. Haney
Reagan S. Haney
JBJoshua H. Butler
Joshua H. Butler
LWLyric A. Wardlaw
Lyric A. Wardlaw
EMEmilio F. Merino
Emilio F. Merino
VMVictoria Mendiola
Victoria Mendiola
MCMaria Belen Cassera
Maria Belen Cassera
Malaria, caused by Plasmodium falciparum, remains a major global health challenge, with an estimated 263 million new infections and 597,000 deaths annually. Increasing resistance to current antimalarial drugs underscores the urgent need for new therapeutics that target novel pathways in the parasite. We previously reported a novel class of β-carboline antimalarials, exemplified by PRC1584, which demonstrated a favorable oral pharmacokinetic profile, in vivo efficacy in Plasmodium berghei-infected mice, and no cross-resistance with other antimalarials in various P. falciparum strains. In this study, we demonstrate that PRC1584 exhibits a high resistance barrier and retains potent activity against fresh Ugandan P. falciparum isolates. PRC1584, along with its more potent analog PRC1697, demonstrated strong in vitro potency against both actively proliferating ring stages and dihydroartemisinin-induced dormant stages. Additionally, our study demonstrated that PfKelch13-C580Y mutation was associated with an increased susceptibility to PRC1584, whereas PfKelch13-R549T and Pfcoronin-R100 K-E107V mutations were not associated with this effect. These findings underscore the therapeutic potential of this new "irresistible" compound class, support a possible novel mechanism of action, and suggest the future development of novel ACTs active against resistant parasites by targeting DHA dormancy, an essential survival mechanism of P. falciparum.

13 October 2026 in Solvent Extraction and Ion Exchange
Verified
Journal Article
Open access
JMJopaul Mathew
Jopaul Mathew
MLMarcy E. Lamb
Marcy E. Lamb
JEJeffrey D Einkauf
Jeffrey D Einkauf
SJSanta Jansone-Popova
Santa Jansone-Popova
In 2018, uranium was designated as one of 35 minerals critical to U.S. national security and the economy.[1] Although it was not included on the 2022 U.S. Critical Materials List,[2] uranium contin...